Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Sarcoidosis, Emergency Medicine


Basics


Description


  • Chronic, multisystem disorder characterized by local accumulation of T lymphocytes and mononuclearphagocytes forming noncaseating epithelioid granulomas
  • Symptoms mainly due to organ dysfunction due to disruption of local tissue architecture:
    • Predominance of lung symptoms
  • ACE and Vitamin D levels may be increased due to secretion from granulomatous tissue
  • Prevalence 10 " “20/100,000 in US and Europe
  • Affects almost all races and geographic locations
  • Symptoms typically begin in patients 10 " “40 yr of age
  • 2.4% lifetime risk to blacks in US, relative to whites at 0.85%

Etiology


Unclear, but appears to be an overly robust cell-mediated immune response to unidentified self- or nonself antigen(s) ‚  

Diagnosis


Signs and Symptoms


History
  • Constitutional:
    • Fatigue, general weakness
    • Fever
  • Skin (25% patients):
    • Rash, lesions
  • Cardiac/respiratory (most patients):
    • Dyspnea
    • Chest pain
    • Palpitations
    • Cough
    • Hemoptysis
  • Neurologic:
    • Nerve palsy (usually CN VII)
    • Seizure
    • Altered mental status
  • Ocular (20% patients):
    • Eye pain
    • Blurred vision
  • Renal:
    • Flank pain
  • Musculoskeletal:
    • Arthralgias

Physical Exam
  • Constitutional:
    • Fever
    • Lethargy
  • Skin:
    • Erythema nodosum
    • Subcutaneous nodules
    • Maculopapules
    • Plaques
    • Infiltrative scars
    • Lupus pernio
  • EENT:
    • Uveitis
    • Keratoconjunctivitis
    • Parotid gland enlargement
  • Neurologic:
    • Nerve palsy (usually CN VII)
  • Respiratory:
    • Rales
    • Rarely wheezing
  • Cardiac ( ¢ ˆ ¼5% patients):
    • Dysrhythmias, conduction abnormalities, AV block
    • CHF (due to restrictive cardiomyopathy)
    • Murmurs (due to papillary muscle dysfunction)
  • Renal:
    • Nephrolithiasis
  • Musculoskeletal:
    • Polyarthralgias
  • L ƒ ¶fgren syndrome:
    • Bilateral hilar adenopathy
    • Erythema nodosum
    • ‚ ±Polyarthralgias
  • Heerfordt " “Waldenstr ƒ ¶m syndrome:
    • Fever
    • Uveitis
    • Parotid gland enlargement
    • ‚ ±CN VII palsy

  • Children <4 yr old classically present with triad of rash, uveitis, and arthritis.
  • Children ≥4 yr old present similarly to adults.

Essential Workup


  • Physical exam with emphasis on lung, skin, eye, heart, and musculoskeletal
  • Pulse oximetry/ABG
  • ECG (dysrhythmias, conduction delays)
  • Slit-lamp eye exam

Diagnosis Tests & Interpretation


Lab
  • Serum ACE elevated in 75% cases
  • Basic chemistry panel
  • LFTs: Mild, usually asymptomatic, mainly elevated alk phos but possible mild elevation transaminases
  • Serum calcium: Hypercalcemia due to excessive vitamin D
  • UA: Hypercalciuria
  • Hypergammaglobulinemia
  • CSF analysis: Lymphocyte predominance, elevated ACE level

Imaging
Chest radiograph (abnormal in 90% sarcoid patients) " ”reason for frequent incidental diagnosis: ‚  
  • Type 1: Bilateral hilar lymphadenopathy
  • Type 2: Lymphadenopathy and parenchymal lung changes (reticular opacities)
  • Type 3: Parenchymal lung changes without hilar lymphadenopathy
  • Type 4: Reticular opacities, pulmonary fibrosis; particularly in upper lobes
  • Radiotracer scans may identify granulomatous disease but is nonspecific

Diagnostic Procedures/Surgery
  • Biopsy:
    • Bronchoscopy and bronchoalveolar lavage
    • Skin lesions if feasible
  • Kveim " “Siltzbach test:
    • Subcutaneous injection of antigen with subsequent spleen biopsy
    • Rarely used

Differential Diagnosis


  • HIV
  • Interstitial lung disease
  • Lymphoma
  • Mycobacterial infection
  • Parathyroid disease

Treatment


Pre-Hospital


Provide supplemental oxygen. ‚  

Initial Stabilization/Therapy


  • Provide supplemental oxygen.
  • Monitor for dysrhythmias.

Ed Treatment/Procedures


  • Patients should be observed without therapy, if possible, since disease resolves spontaneously in 50% patients.
  • Initiate steroids in patients demonstrating 1 of the following:
    • Symptomatic or progressive stage II pulmonary disease
    • Stage III pulmonary disease
    • Malignant hypercalcemia
    • Severe ocular disease
    • Neurologic sequelae
    • Nasopharyngeal/laryngeal involvement
  • Consider topical corticosteroids and cycloplegic agents for anterior uveitis or dermatologic manifestations.

Medication


  • Prednisone: 10 " “80 mg (peds: 0.5 " “2 mg/kg) PO QD
  • Lower doses for hypercalcemic nephropathy and mild to moderate disease
  • Higher doses for neurosarcoidosis

Follow-Up


Disposition


Admission Criteria
  • Hypoxia
  • Patients with moderate to severe respiratory symptoms
  • Significant cardiac conduction delays
  • Severe thrombocytopenia

Discharge Criteria
Follow-up is established. ‚  
Issues for Referral
  • Cardiology:
    • For any conduction disturbances or CHF
  • Rheumatology:
    • For routine care and follow-up:
      • ¢ ˆ ¼q2mo for patients with active disease on steroids, q3 " “4mo for asymptomatic patients
  • Pulmonary:
    • For formal pulmonary function testing (to monitor for progression of restrictive lung disease) with spirometry and DLCO
  • Ophthalmology:
    • Within 48 hr for acute uveitis

Follow-Up Recommendations


  • Restrict excess calcium from the diet.
  • Monitor for complications related to chronic steroid therapy

Pearls and Pitfalls


  • Evaluate patients with chest radiographs to determine stage and progression of disease.
  • Prednisone is treatment of choice for exacerbations of disease.
  • Monitor for signs of hypercalcemia and related complications.
  • Be aware of acute neurologic and ocular sequelae.

Additional Reading


  • Baughman ‚  RP. Pulmonary sarcoidosis. Clin Chest Med.  2004;25:521 " “530.
  • Fauci ‚  AS, Braunwald ‚  E, Kasper ‚  DL, et al. Harrisons principles of internal medicine. 17th ed. New York, NY: McGraw-Hill Professional; 2008.
  • Iannuzzi ‚  MC, Rybicki ‚  BA, Teirstein ‚  AS. Sarcoidosis. N Engl J Med.  2007;357:2153 " “2165.
  • King ‚  TE. Sarcoidosis. Updated Apr 18, 2011. Available at www.UpToDate.com. Accessed on January 2013.

See Also (Topic, Algorithm, Electronic Media Element)


  • Dyspnea
  • HIV/AIDS
  • Hyperparathyroidism
  • Tuberculosis

Codes


ICD9


  • 135 Sarcoidosis
  • 517.8 Lung involvement in other diseases classified elsewhere

ICD10


  • D86.0 Sarcoidosis of lung
  • D86.3 Sarcoidosis of skin
  • D86.9 Sarcoidosis, unspecified
  • D86.85 Sarcoid myocarditis
  • D86.1 Sarcoidosis of lymph nodes
  • D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes
  • D86.81 Sarcoid meningitis
  • D86.82 Multiple cranial nerve palsies in sarcoidosis
  • D86.83 Sarcoid iridocyclitis
  • D86.84 Sarcoid pyelonephritis
  • D86.86 Sarcoid arthropathy
  • D86.87 Sarcoid myositis
  • D86.89 Sarcoidosis of other sites
  • D86.8 Sarcoidosis of other sites
  • D86 Sarcoidosis

SNOMED


  • 31541009 Sarcoidosis (disorder)
  • 24369008 Pulmonary sarcoidosis (disorder)
  • 55941000 cutaneous sarcoidosis (disorder)
  • 75403004 Cardiac sarcoidosis
  • 193251003 Sarcoid myopathy
  • 230193008 Neurosarcoidosis
  • 234526006 Ocular sarcoidosis (disorder)
  • 64757003 lymph node sarcoidosis (disorder)
Copyright © 2016 - 2017
Doctor123.org | Disclaimer